Early trials of tacrolimus in renal transplant recipients have not revealed hearing loss as an adverse effect. Here, we present a case report and a review of the literature of deafness after tacrolimus use. The review of the literature and our experience suggested that the possible reason for hearing loss could be due to an initiation of a sudden spike in the tacrolimus serum level, which was later worsened by its cumulative toxic effect.

Download full-text PDF

Source
http://dx.doi.org/10.6002/ect.2017.0114DOI Listing

Publication Analysis

Top Keywords

deafness tacrolimus
8
hearing loss
8
review literature
8
sensorineural deafness
4
tacrolimus
4
tacrolimus early
4
early trials
4
trials tacrolimus
4
tacrolimus renal
4
renal transplant
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!